HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Supernumerary ring chromosomes in dermatofibrosarcoma protuberans may contain sequences from 8q11.2-qter and 17q21-qter: a combined cytogenetic and comparative genomic hybridization study.

Abstract
Dermatofibrosarcoma protuberans (DFSP) presents with characteristic cytogenetic features such as reciprocal t(17;22)(q22;q13) or, more commonly, supernumerary ring chromosomes containing sequences from chromosomes 17 and 22. Here, we report the identification of a novel abnormality in a 43-year-old woman with DFSP. Cytogenetic analysis of tumor cells showed the presence of a supernumerary ring chromosome as the sole anomaly. Amplification of 8q11.2 approximately qter and 17q21 approximately qter sequences was confirmed by comparative genomic hybridization (CGH); the present case apparently lacked amplification of chromosome 22. To our knowledge, this is the first case indicating that the ring chromosome in DFSP is possibly associated with amplified material from chromosomes 8 and 17.
AuthorsJ Nishio, H Iwasaki, Y Ohjimi, M Ishiguro, T Isayama, M Naito, Y Kaneko, M Kikuchi
JournalCancer genetics and cytogenetics (Cancer Genet Cytogenet) Vol. 129 Issue 2 Pg. 102-6 (Sep 2001) ISSN: 0165-4608 [Print] United States
PMID11566338 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Chromosome Aberrations (diagnosis, genetics)
  • Chromosome Disorders
  • Chromosomes, Human, Pair 17 (genetics)
  • Chromosomes, Human, Pair 8 (genetics)
  • Dermatofibrosarcoma (genetics, pathology)
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Metaphase
  • Ring Chromosomes
  • Skin Neoplasms (genetics, pathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: